Cargando…

Suppressive effect of epigallocatechin‐3‐O‐gallate on endoglin molecular regulation in myocardial fibrosis in vitro and in vivo

Epigallocatechin‐3‐O‐gallate (EGCG), derived from green tea, has been studied extensively because of its diverse physiological and pharmacological properties. This study evaluates the protective effect of EGCG on angiotensin II (Ang II)‐induced endoglin expression in vitro and in vivo. Cardiac fibro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chiu‐Mei, Chang, Hang, Wang, Bao‐Wei, Shyu, Kou‐Gi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082397/ https://www.ncbi.nlm.nih.gov/pubmed/27306149 http://dx.doi.org/10.1111/jcmm.12895

Ejemplares similares

MicroRNA-208a Increases Myocardial Fibrosis via Endoglin in Volume Overloading Heart
por: Wang, Bao-Wei, et al.
Publicado: (2014)

Epigallocatechin-3-Gallate Ameliorates Glucocorticoid-Induced Osteoporosis of Rats in Vivo and in Vitro
por: Liu, Shengye, et al.
Publicado: (2018)

Anti-osteoclastogenic effect of epigallocatechin gallate-functionalized gold nanoparticles in vitro and in vivo
por: Zhu, Shenting, et al.
Publicado: (2019)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017)

Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies
por: Kang, Ki Sung, et al.
Publicado: (2010)

Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo
por: Tran, Phan LCHB, et al.
Publicado: (2010)

In Vitro Antifungal Activity of Epigallocatechin 3-O-Gallate against Clinical Isolates of Dermatophytes
por: Park, Bong Joo, et al.
Publicado: (2011)

In Vitro Toxicity of Epigallocatechin Gallate in Rat Liver Mitochondria and Hepatocytes
por: Kucera, Otto, et al.
Publicado: (2015)

Effects of epigallocatechin-3-gallate on bovine oocytes matured in vitro
por: Huang, Ziqiang, et al.
Publicado: (2018)

In Vitro Evaluation of the Antiviral Activity of the Synthetic Epigallocatechin Gallate Analog-Epigallocatechin Gallate (EGCG) Palmitate against Porcine Reproductive and Respiratory Syndrome Virus
por: Zhao, Chunjian, et al.
Publicado: (2014)

Epigallocatechin Gallate Attenuates Gentamicin-Induced Nephrotoxicity by Suppressing Apoptosis and Ferroptosis
por: Yue, Lin, et al.
Publicado: (2022)

The Effect of (-)-Epigallocatechin 3-O - Gallate In Vitro and In Vivo in Leishmania braziliensis: Involvement of Reactive Oxygen Species as a Mechanism of Action
por: Inacio, Job D. F., et al.
Publicado: (2014)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo
por: Kuduvalli, Shreyas S., et al.
Publicado: (2023)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Cardioprotective effect of epigallocatechin-3-gallate against myocardial infarction in hypercholesterolemic rats
por: ZHONG, WEI, et al.
Publicado: (2015)

Epigallocatechin-3-Gallate Suppresses Human Herpesvirus 8 Replication and Induces ROS Leading to Apoptosis and Autophagy in Primary Effusion Lymphoma Cells
por: Tsai, Ching-Yi, et al.
Publicado: (2017)

Antioxidant and Cytoprotective Effects of (−)-Epigallocatechin-3-(3″-O-methyl) Gallate
por: Kim, Eunji, et al.
Publicado: (2019)

Preparation of epigallocatechin gallate-loaded nanoparticles and characterization of their inhibitory effects on Helicobacter pylori growth in vitro and in vivo
por: Lin, Yu-Hsin, et al.
Publicado: (2014)

Effect of epigallocatechin gallate on dental biofilm of Streptococcus mutans: An in vitro study
por: Schneider-Rayman, Mor, et al.
Publicado: (2021)

Does ( −)-epigallocatechin-3-gallate protect the neurotoxicity induced by bisphenol A in vivo?
por: El Tabaa, Manar Mohammed, et al.
Publicado: (2022)

Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
por: Zhong, Ying, et al.
Publicado: (2012)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Food-Grade Encapsulation Systems for (−)-Epigallocatechin Gallate
por: Shi, Meng, et al.
Publicado: (2018)

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
por: Granja, Andreia, et al.
Publicado: (2017)

Effect of Epigallocatechin Gallate on Viability of Kudoa septempunctata
por: Shin, Sang Phil, et al.
Publicado: (2020)

Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition
por: Kim, Sejin, et al.
Publicado: (2023)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

Src Mediates Epigallocatechin-3-O-Gallate-Elicited Acid Sphingomyelinase Activation
por: Kumazoe, Motofumi, et al.
Publicado: (2020)

Epigallocatechin‐3‐O‐gallate modulates the diversity of gut microbiota in ovariectomized rats
por: Zhang, Beilin, et al.
Publicado: (2020)

Epigallocatechin-3-gallate Attenuates Renal Damage by Suppressing Oxidative Stress in Diabetic db/db Mice
por: Yang, Xiu Hong, et al.
Publicado: (2016)

Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro
por: Oliviero, Francesca, et al.
Publicado: (2013)

Hyperbaric oxygen‐induced long non‐coding RNA MALAT1 exosomes suppress MicroRNA‐92a expression in a rat model of acute myocardial infarction
por: Shyu, Kou‐Gi, et al.
Publicado: (2020)

Antiallodynic effect of intrathecal epigallocatechin-3-gallate due to suppression of reactive oxygen species
por: An, Sang Soon, et al.
Publicado: (2014)

Epigallocatechin gallate triggers apoptosis by suppressing de novo lipogenesis in colorectal carcinoma cells
por: Khiewkamrop, Phuriwat, et al.
Publicado: (2022)

Exploring the Absorption Mechanisms of Imidazolium-Based Ionic Liquids to Epigallocatechin Gallate
por: Luo, Yingjie, et al.
Publicado: (2022)

Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway
por: Cui, Yue, et al.
Publicado: (2021)

Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis
por: Arffa, M. L., et al.
Publicado: (2016)

The epigallocatechin gallate derivative Y(6) reverses drug resistance mediated by the ABCB1 transporter both in vitro and in vivo
por: Wen, Yan, et al.
Publicado: (2019)

The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo
por: Trovò, L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nqco1ulaq7eerefe60p7gn74b3